Bio-Rad Laboratories Stock Price and Value Analysis

Should you buy Bio-Rad Laboratories stock? (NYSE:BIO). Let's see how it does in our automated value investing analysis system.

  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company pays no dividend.

Inside the BIO Numbers

BIO Price
(Bio-Rad Laboratories stock price per share)
[?] BIO Fair Price
(based on intrinsic value)
[?] BIO Safety Price (based on a variable margin of safety) $149.65
[?] PE Ratio versus Sector 75% lower than other Healthcare stocks
[?] PE Ratio versus Industry 67% lower than other Diagnostics & Research stocks
[?] Cash Yield 0.36%
[?] Free Cash Flow Jitter 258%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 592,970 shares shorted. With 21,278,305 shares available for purchase and an average trading volume over the past 10 trading days of 99,800, it would take at least 5.942 days for all of the short holders to cover their shorts.

Is Bio-Rad Laboratories Stock on Sale?

We believe that Bio-Rad Laboratories may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Bio-Rad Laboratories looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy BIO Stock?

Does Bio-Rad Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.